6:25 PM
Dec 12, 2012
 |  BC Extra  |  Financial News

Biocartis raises EUR 34.5 million in series D

Diagnostic company Biocartis S.A. (Lausanne, Switzerland) raised EUR 34.5 million ($44.5 million) in a series D round led by existing investor PMV. Existing investors RMM; Valiance; Debiopharm Group (Lausanne, Switzerland);...

Read the full 136 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >